Shi M - Search Results

1

A study of capecitabine metronomic chemotherapy is non-inferior to conventional chemotherapy as maintenance strategy in responders after induction therapy in metastatic colorectal cancer.

Shi M, Ma T, Xi W, Jiang J, Wu J, Zhou C, Yang C, Zhu Z, Zhang J. Shi M, et al. Trials. 2020 Mar 6;21(1):249. doi: 10.1186/s13063-020-4194-6. Trials. 2020. PMID: 32143730 Free PMC article.

2

[Therapeutic arrangement and strategies in perioperative treatment of locally advanced gastric cancer from the view of whole-process management].

Shi M, Zhang J, Zhu Z. Shi M, et al. Zhonghua Wei Chang Wai Ke Za Zhi. 2018 Oct 25;21(10):1093-1098. Zhonghua Wei Chang Wai Ke Za Zhi. 2018. PMID: 30370505 Chinese.

3

Dose-finding study of modified FLOT (mFLOT) regimen as first-line treatment in Chinese patients with metastatic adenocarcinoma of stomach.

Zhou C, Ma T, Shi M, Xi W, Wu J, Yang C, Zhu Z, Zhang J. Zhou C, et al. Among authors: shi m. Cancer Chemother Pharmacol. 2020 Jan;85(1):113-119. doi: 10.1007/s00280-019-03982-4. Epub 2019 Nov 5. Cancer Chemother Pharmacol. 2020. PMID: 31691079

4

Camrelizumab and metronomic capecitabine for patients with treatment-refractory solid tumors (McCREST trial).

Zhou C, Shangguan C, Shi M, Xi W, Wu J, Yang H, Guo L, Cai Q, Shi Y, Liu J, Zhang J. Zhou C, et al. Among authors: shi m, shi y. Future Oncol. 2022 Jul;18(23):2495-2503. doi: 10.2217/fon-2021-1579. Epub 2022 Jun 15. Future Oncol. 2022. PMID: 35703115 Review.

5

Efficacy and safety of docetaxel plus oxaliplatin and capecitabine in the first line treatment of advanced gastric adenocarcinoma.

Liu Y, Ye Z, Xi W, Ma T, Shi M, Yang L, Zhu Z, Zhang J. Liu Y, et al. Among authors: shi m. Biomed Res Int. 2013;2013:971096. doi: 10.1155/2013/971096. Epub 2013 Sep 15. Biomed Res Int. 2013. PMID: 24151630 Free PMC article.

6

Capecitabine plus irinotecan versus 5-FU/leucovorin plus irinotecan in the treatment of colorectal cancer: a meta-analysis.

Guo Y, Shi M, Shen X, Yang C, Yang L, Zhang J. Guo Y, et al. Among authors: shi m. Clin Colorectal Cancer. 2014 Jun;13(2):110-8. doi: 10.1016/j.clcc.2013.12.004. Epub 2013 Dec 27. Clin Colorectal Cancer. 2014. PMID: 24461997

7

Postoperative BMI Loss at One Year Correlated with Poor Outcomes in Chinese Gastric Cancer Patients.

Wang N, Jiang J, Xi W, Wu J, Zhou C, Shi M, Wang C, Zhu Z, Liu J, Zhang J. Wang N, et al. Among authors: shi m. Int J Med Sci. 2020 Aug 25;17(15):2276-2284. doi: 10.7150/ijms.46530. eCollection 2020. Int J Med Sci. 2020. PMID: 32922192 Free PMC article.

8

Development and validation of risk and prognostic nomograms for bone metastases in Chinese advanced colorectal cancer patients.

Wang N, Liu F, Xi W, Jiang J, Xu Y, Guan B, Wu J, Zhou C, Shi M, Zhu Z, Xu Y, Liu J, Zhang J. Wang N, et al. Among authors: shi m. Ann Transl Med. 2021 May;9(10):875. doi: 10.21037/atm-21-2550. Ann Transl Med. 2021. PMID: 34164509 Free PMC article.

9

Addition of sintilimab to nanoparticle albumin-bound paclitaxel and S-1 as adjuvant therapy in stage IIIC gastric cancer.

Mei Y, Shi M, Zhu Z, Yuan H, Yan C, Li C, Feng T, Yan M, Zhang J, Zhu Z. Mei Y, et al. Among authors: shi m. Future Oncol. 2022 Jan;18(2):139-148. doi: 10.2217/fon-2021-1020. Epub 2021 Dec 8. Future Oncol. 2022. PMID: 34877867

10

Oxaliplatin plus S-1 with intraperitoneal paclitaxel for the treatment of Chinese advanced gastric cancer with peritoneal metastases.

Shi M, Yang Z, Lu S, Liu W, Ni Z, Yao X, Hua Z, Feng R, Zheng Y, Wang Z, Sah BK, Chen M, Zhu Z, He C, Li C, Zhang J, Yan C, Yan M, Zhu Z. Shi M, et al. BMC Cancer. 2021 Dec 18;21(1):1344. doi: 10.1186/s12885-021-09027-5. BMC Cancer. 2021. PMID: 34922478 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,957 results

Search Page

Filters